Agios Pharmaceuticals Inc Bruttomarge
Was ist das Bruttomarge von Agios Pharmaceuticals Inc?
Bruttomarge von Agios Pharmaceuticals Inc ist 89.26%
Was ist die Definition von Bruttomarge?
Die Bruttomarge ist die Differenz zwischen Umsatz und Kosten der verkauften Waren, dividiert durch den Umsatz und in Prozent ausgedrückt.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttomarge von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Agios Pharmaceuticals Inc
Was macht Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Unternehmen mit bruttomarge ähnlich Agios Pharmaceuticals Inc
- Darktrace plc hat Bruttomarge von 89.21%
- Proactis Plc hat Bruttomarge von 89.23%
- Tian An Australia hat Bruttomarge von 89.23%
- Bajaj Finance hat Bruttomarge von 89.24%
- Nirlon hat Bruttomarge von 89.25%
- Ackroo hat Bruttomarge von 89.26%
- Agios Pharmaceuticals Inc hat Bruttomarge von 89.26%
- UroGen Pharma hat Bruttomarge von 89.27%
- SREI Infrastructure Finance hat Bruttomarge von 89.29%
- KemPharm hat Bruttomarge von 89.29%
- Beijing Baolande Software hat Bruttomarge von 89.31%
- BF Utilities hat Bruttomarge von 89.33%
- Doximity hat Bruttomarge von 89.34%